Privacy Examiner Launches Service to Flag HIPAA Risks from Tracking Tech on Healthcare Websites

TL;DR: Privacy Examiner now offers a non‑invasive scan that flags tracking technologies on healthcare websites capable of linking identifiers to patient visits, creating potential HIPAA exposure. The launch addresses an estimated 400,000‑600,000 U.S. medical sites with at least one risky configuration.

Context: Most medical practices build their public sites using standard marketing stacks not designed for regulated healthcare environments. These stacks often include visitor identification, call tracking, or IP enrichment tools that can pair an IP address or device ID with a healthcare‑related page view. When such linkage occurs, federal privacy rules may apply, turning a technical detail into a compliance concern.

Key Facts: Michael Knorr, President of Privacy Examiner, notes that most healthcare websites use marketing stacks unsuitable for regulated settings, and that tracking technologies can link identifiers to healthcare visits, creating privacy and compliance exposure if not governed. An internal market analysis estimates 750,000–900,000 U.S. healthcare providers operate public‑facing websites, with 65–75% showing at least one risky configuration, implying roughly 400,000–600,000 sites face material risk from tracking technologies. From 2022 to 2024, the HHS Office for Civil Rights clarified that federal healthcare privacy rules may apply when online tracking links identifiers to healthcare‑related interactions.

What It Means: Website owners should review third‑party scripts for any tool that collects identifiers alongside health‑related page views, as this combination can trigger HIPAA scrutiny even without a data breach. Practical steps include maintaining an inventory of embedded technologies, configuring them to avoid collecting personal identifiers on health pages, and monitoring for re‑appearance of flagged tools. Privacy Examiner’s scan provides an external, observable risk surface without guaranteeing compliance or offering legal advice.

What to watch next: Regulators may issue further guidance on permissible tracking in healthcare contexts, and vendors could begin offering HIPAA‑aligned marketing stacks that reduce identifier linkage.